Pharmaceuticals - Cambridge, England, United Kingdom
Our company is dedicated to early-stage preclinical drug discovery. Our focus is on making research in the fields of biomedicine.We are making new drugs for promising biotargets. We also develop new methods. So, our activities can be divided into two big parts. 1. Preclinical drug discovery of medicines with high innovative potential. This includes drug design of small molecule drugs for anti-cancer treatment and Alzheimer's disease treatment. The biotargets include stem cells signaling pathways, like Wnt, Shh, EGFR. These biotargets are important for both cancer and degenerative-diseases like Alzheimer s. Our team has experience of working in top leading research centers in this field. Also we collaborate with best scientists worldwide in order to deliver innovative products of high quality.2. Methods development. This includes our volunteer distributed computing platform, called DrugDiscovery@home (www.drugdiscoveryathome.com). In this platform we include the most advanced open source software in the field of in silico drug design. In volunteer distributed computing people around the world, which want to help developing new medicines, donate their computational resources (computers, tablets, smartphones etc.).
Gmail
Google Apps
DigitalOcean